English | Español

Bristol-Myers Squibb
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
Robert Hadley | May 14, 2017

Partnership to launch study of two drugs, chemotherapy to treat lung cancer
Chandra Lye | May 11, 2017

Opdivo given European approval for patients with head and neck squamous cell cancer
Robert Hadley | Apr 14, 2017

FDA to speed Opdivo review for use as colorectal cancer drug
Robert Hadley | Apr 10, 2017

Bristol-Myers Squibb to contunue testing Opdivo for brain tumors
Robert Hadley | Apr 7, 2017

Early tests show Opdivo triples life expectancy in lung-cancer patients
Kyle Perrotti | Apr 6, 2017

Parker Institute, Cancer Research Institute join forces for project
Erianne Leatherman | Apr 5, 2017

BMS, Foundation Medicine partner on predictive biomarker project

Trending
+ Pharmaceuticals
Patient Daily | Mar 20, 2025

Patients Come First spokesperson on drug pricing reform: 'Vulnerable patients are depending on them to fix 340B'
C.D. Marsden | Mar 14, 2025

Solidarity Health to Musk, RFK, Jr: ‘Enforce the CMS Hospital Price Transparency Rule’
+ Pharmaceuticals
Patient Daily | Mar 18, 2025

Redler’s LTC Pharmacy Owner on 340B reform: 'Only 35% of participating hospitals and clinics provide service to underserved areas'
+ Pharmaceuticals
Patient Daily | Mar 14, 2025

Research links new CDKL gene variants to neurodevelopmental disorders